)
Weight Watchers (WW) investor relations material
Weight Watchers Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Emerged from Chapter 11 bankruptcy in June 2025, applying fresh start accounting and establishing a new capital structure, resulting in non-comparable Predecessor and Successor periods.
Achieved ongoing progress in multi-year transformation, with improved financial footing, positive operating cash flow in Q2, and reaffirmed full-year 2026 revenue and adjusted EBITDA guidance.
Q2 2026 revenue was $162.3 million, down 14% year-over-year, driven by Behavioral declines but offset by strong Clinical growth.
Net income for Q2 2026 was $14.1 million, including a $4.6 million gain from debt extinguishment; diluted EPS was $1.41.
Leadership transition occurred in March 2026, with the CEO resigning and an Interim Office of the Chief Executive established.
Financial highlights
Q2 2026 revenue: $162.3 million (down 14% year-over-year); ARPU increased 10.2% to $20.90 due to a shift to higher-value tiers.
Clinical subscription revenue grew 30.4% to $39.9 million, now 24.6% of total revenue; Behavioral subscription revenue declined 22.7% to $121.5 million.
Q2 net income was $14.1 million; adjusted EBITDA was $39.8 million (24.5% margin); Q2 gross margin was 70.3%, with adjusted gross margin at 73.6%.
Marketing expense was $47.9 million (29.5% of revenue), higher than prior year due to reorganization.
Cash and cash equivalents at June 30, 2026, were $101.5 million.
Outlook and guidance
Full-year 2026 revenue guidance reaffirmed at $620–$635 million and adjusted EBITDA at $105–$115 million.
Clinical subscription revenue expected to represent 25–30% of 2026 total revenue.
Continued growth in Core+ subscribers and moderation in behavioral subscriber declines anticipated.
Expect positive operating cash flow for full year 2026; no need for additional liquidity anticipated in the next 12 months.
Management expects continued market disruption and competitive pressures, especially from rapid adoption of GLP-1 medications and new entrants.
- Board urges support for director nominees and revamped executive compensation post-bankruptcy.WW
Proxy filing - Settlement with former CEO includes major payments and mutual covenants amid leadership transition.WW
Proxy filing - Clinical growth and strong margins offset net loss; 2026 guidance and debt reduction reaffirmed.WW
Q1 2026 - Shareholders will vote on directors, auditor, and executive pay after a transformative restructuring.WW
Proxy filing - Clinical subscriber growth and higher ARPU drive 2026 outlook despite behavioral headwinds.WW
Q4 2025 - GLP-1 integration, financial restructuring, and targeted programs drive innovation and growth.WW
CJS Securities 26th Annual "New Ideas for the New Year” Investor Conference - Q3 revenue and subscribers fell, but clinical growth and cost actions supported margin gains.WW
Q3 2024 - Q2 2024 revenue fell 10.9% as clinical subscribers surged 120% and cost savings were targeted.WW
Q2 2024 - Clinical growth and cost cuts offset declines, but bankruptcy and high debt loom.WW
Q1 2025
Next Weight Watchers earnings date
Next Weight Watchers earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage